- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
Sinae Active Pharmaceutical Ingredient (API) fabrica, supplementum, Factory
Jiangsu Run'an Pharmaceutical Co, Ltd., subsidiaria omnino possessa de Jiangsu Chiatai Qingjiang Pharmaceutical Co, Ltd., modernus summus tech pharmaceuticus societas specialis in R&D, productionis et venditio fertilitatis ordinandae medicinae et varietatis APIs. Project constructionem mense Novembri 2018 incepit, LIX mu aream obtegens, cum tota obsidione 160 decies Yuan et tota area aedificium 25000 quadratum metrorum.
Praecipua activum medicamentum pharmaceuticum (API) producta: Hydrochloridem Gemcitabinum, Celecoxib, bromhexinum hydrochloridum, Iguratimod, Apremilast, Citrate Tofactinib, Crisaborole, Urapidil Hydrochloride, Sugammadex Natrium, Garlicin, Dexmedetomidine Hydrochloride, Rocuronium Bromidum, Finerenone, etc. elit mundi genus facti et productorum gignentium opificem per constantem emendationem et innovationem in technologiarum, et occasiones praeclarum negotium praebent sodalibus nostris per orbem terrarum. Munus nostrum ad praestantes operas emptores nobis permisit solidas relationes cum sociis nostris toto orbe includere.
- View as
169590-42-5
169590-42-5 est pro medicamento nonsteroidali anti-inflammatorio, pro medicamento OSTEOARTHRITIS, ARTHRITIS ARTHRITIS MEDICO, ARTHRITIS ARTHRITIS rheumatoidei juvenili medicamento.
Lege plusMitte Inquisitionem
Celecoxib API
Celecoxib API est pro medicamento nonsteroidali anti-inflammatorio, pro medicamento OSTEOARTHRITIS, ARTHRITIS ARTHRITIS MEDICAMENTUM, ARTHRITIS ARTHRITIS rheumatoidei juvenili medicamento.
Lege plusMitte Inquisitionem![(3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylate](https://i.trade-cloud.com.cn/upload/7632/-3r-4r-4-methyl-3-methyl-7h-pyrrolo-2-3-d-pyrimidin-4-ylamino-b-oxo-1-piperidinepropanenitrile-2-hydroxy-1-2-3-propanetricarboxylate_63706.jpg?x-oss-process=image/format,webp "(3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylate")
(3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylate
(3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylatum est medicamento arthritis rheumatoidei, medicamento arthritis psoriatic, spondylitis medicamento ankylosing, polyarticularis utique arthritis juvenilis idiopathica medicamento, medicamento ulcerativa colitis.
Lege plusMitte Inquisitionem
CAS NO.540737-29-9
CAS NO.540737-29-9 medicamentum arthritis rheumatoidei, arthritis psoriaticum medicamentum, spondylitis medicamentum ankylosing, polyarticularis utique pharmacum arthritis juvenile idiopathicum, medicamentum ulcerativum.
Lege plusMitte Inquisitionem
CAS 540737-29-9
CAS 540737-29-9 est medicamentum arthritis rheumatoidis, medicamentum arthritis psoriaticum, medicamentum spondylitis ankylosing, polyarticularis utique pharmacum arthritis juvenilis idiopathica, medicamento ulcerativa.
Lege plusMitte Inquisitionem
540737-29-9
540737-29-9 est medicamento arthritis rheumatoidei, medicamento arthritis psoriaticae, medicamento ankylosing spondylitis, polyarticularis cursus juvenilis arthritis idiopathica medicamento, medicamento ulcerativi colitis.
Lege plusMitte Inquisitionem
Quiescere potes ex officina nostra emere Active Pharmaceutical Ingredient (API) in Sinis. Pharmaceutical Run'an professionalis Sinarum Active Pharmaceutical Ingredient (API) fabrica et supplementum, qualitas products alta praebere possumus. Grata res emendas ex officina nostra.
